We have also reported that proteasome inhibitors activate both Nrf2 and ATF4 and cooperatively induce the expression of the cystine transporter xCT in bladder cancer cells via Nrf2 binding to ARE and ATF4 binding to amino acid response elements (AAREs), respectively [123]. The gene discussed is NFE2L2; the disease is urinary bladder cancer.